Is Iyuzeh in shortage in 2026? Get the latest update on Iyuzeh availability, pricing, and what to do if you can't find your prescription.
If you rely on Iyuzeh for your glaucoma or ocular hypertension, you may be wondering: is there an Iyuzeh shortage in 2026? And if not, why is it so hard to find at the pharmacy?
Here's the latest on Iyuzeh availability, cost, and what you can do if your pharmacy doesn't have it.
As of early 2026, Iyuzeh is not listed on the FDA's official drug shortage database. Unlike some widely-used medications that have experienced genuine supply disruptions, Iyuzeh's availability issues are more about limited pharmacy stocking than a manufacturing shortage.
Thea Pharma Inc., the maker of Iyuzeh, continues to produce and distribute the medication. The challenge is that many retail pharmacies simply don't carry it on their shelves because it's a newer, brand-name medication with relatively limited demand compared to widely-used generics.
Several factors contribute to the difficulty patients face when trying to fill an Iyuzeh prescription:
Iyuzeh was FDA-approved in November 2022 and launched commercially in October 2023. Many pharmacies haven't added it to their regular inventory. Large chain pharmacies tend to stock medications based on volume — and Iyuzeh, as a niche preservative-free option, doesn't move as quickly as generic Latanoprost.
There is no generic version of preservative-free Latanoprost. While generic Latanoprost (preserved with BAK) costs just $10–$30 per month, Iyuzeh is the only game in town for patients who need the preservative-free formulation. Pharmacies can't substitute a generic, so they need to specifically order the brand product.
Many insurance plans require prior authorization and step therapy for Iyuzeh. This means your doctor needs to document that you've tried generic Latanoprost first and that you have a medical reason for needing the preservative-free version. These administrative requirements can delay access and discourage some pharmacies from stocking the drug.
For a deeper dive, read our full article on why Iyuzeh is so hard to find in 2026.
Here's what you can expect to pay for Iyuzeh in 2026:
By comparison, generic preserved Latanoprost costs $10–$30 per month — a significant difference that explains why insurance companies push back on covering Iyuzeh.
For tips on reducing your out-of-pocket costs, check out our guide to saving money on Iyuzeh.
Thea Pharma has been expanding access to Iyuzeh through several programs:
These programs are not available to patients on Medicare, Medicaid, or other federal/state healthcare programs.
If you need Iyuzeh today, here are your best options:
For a complete walkthrough, read our guide on how to find Iyuzeh in stock near you.
If you can't find Iyuzeh or afford it, talk to your eye doctor about alternatives. Options include:
Important: Never stop your glaucoma medication without talking to your doctor. Untreated elevated eye pressure can lead to irreversible vision loss.
Iyuzeh is not in a formal shortage in 2026, but it remains hard to find at many local pharmacies due to its newness, brand-name-only status, and insurance barriers. The best strategies for getting Iyuzeh are using Medfinder to check local availability, enrolling in Thea Pharma's home delivery program, and taking advantage of manufacturer savings cards to reduce costs.
Stay informed about your glaucoma treatment — read more about Iyuzeh side effects and everything you need to know about Iyuzeh.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
